This month, European Pharmaceutical Review features a piece from ReNewVax’s Chief Executive Dr. Neil Murray for its Formulation issue. In the piece, Neil explores the importance of new bacterial vaccines in the context of antimicrobial resistance and examines...
This month, North West Business Insider has named ReNewVax as one of thirty businesses across the region carrying out exciting work in their sectors. The Most Exciting Companies list features a range of companies shaking up their sectors, whether it be...
ReNewVax appears on The Northern Agenda podcast ReNewVax was invited to appear on The Northern Agenda’s second birthday podcast! The episode saw hosts Rob Parsons and Dan McLaughlin discuss the last two years in Northern politics and ask whether the North is...
ReNewVax showcased in the latest edition of Laboratory News ReNewVax is featured in the April/May edition of Laboratory News with an article highlighting our RVX-001 pneumococcal vaccine program. In the article, we explore how we are deploying our novel platform...
